pioglitazone
Generic: pioglitazone
Labeler: macleods pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
pioglitazone
Generic Name
pioglitazone
Labeler
macleods pharmaceuticals limited
Dosage Form
TABLET
Routes
Active Ingredients
pioglitazone hydrochloride 15 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
33342-054
Product ID
33342-054_7d118937-d5b2-402f-8e24-f70a48c1d432
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202467
Listing Expiration
2026-12-31
Marketing Start
2013-02-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
33342054
Hyphenated Format
33342-054
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pioglitazone (source: ndc)
Generic Name
pioglitazone (source: ndc)
Application Number
ANDA202467 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 15 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (33342-054-07)
- 90 TABLET in 1 BOTTLE (33342-054-10)
- 100 TABLET in 1 BOX, UNIT-DOSE (33342-054-12)
- 500 TABLET in 1 BOTTLE (33342-054-15)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7d118937-d5b2-402f-8e24-f70a48c1d432", "openfda": {"upc": ["0333342056153", "0333342055101", "0333342056078", "0333342056108", "0333342054104", "0333342055071"], "unii": ["JQT35NPK6C"], "rxcui": ["312440", "312441", "317573"], "spl_set_id": ["482cef76-0623-4b4f-a0ea-f008c97b2281"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (33342-054-07)", "package_ndc": "33342-054-07", "marketing_start_date": "20130214"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (33342-054-10)", "package_ndc": "33342-054-10", "marketing_start_date": "20130214"}, {"sample": false, "description": "100 TABLET in 1 BOX, UNIT-DOSE (33342-054-12)", "package_ndc": "33342-054-12", "marketing_start_date": "20130214"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (33342-054-15)", "package_ndc": "33342-054-15", "marketing_start_date": "20130214"}], "brand_name": "Pioglitazone", "product_id": "33342-054_7d118937-d5b2-402f-8e24-f70a48c1d432", "dosage_form": "TABLET", "pharm_class": ["PPAR alpha [CS]", "PPAR gamma [CS]", "Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor Activity [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "33342-054", "generic_name": "Pioglitazone", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pioglitazone", "active_ingredients": [{"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "15 mg/1"}], "application_number": "ANDA202467", "marketing_category": "ANDA", "marketing_start_date": "20130214", "listing_expiration_date": "20261231"}